Thor Equities attracts 4th life sciences tenant from NYC to JC

Jessica Perry//January 5, 2024//

95 Greene St. in Jersey City is attracting life sciences tenants from across the Hudson River. - JLL

95 Greene St. in Jersey City is attracting life sciences tenants from across the Hudson River. - JLL

95 Greene St. in Jersey City is attracting life sciences tenants from across the Hudson River. - JLL

95 Greene St. in Jersey City is attracting life sciences tenants from across the Hudson River. - JLL

Thor Equities attracts 4th life sciences tenant from NYC to JC

Jessica Perry//January 5, 2024//

Listen to this article

Charting the same course across the Hudson River from Manhattan to as others recently, announced RegenLab USA is joining the roster at Thor Equities Group‘s lab-ready property at 95 Greene St.

RegenLab USA, which manufacturers devices for the production of regenerative cell therapy, signed a long-term lease and will relocate to the sixth floor of the recently completed property from New York’s Brooklyn Army Terminal.

The new tenant is due to occupy 15,792 square feet of space in the second quarter of 2024, JLL said. RegenLab plans to use the space for offices as well as research and manufacturing of medical devices and platelet rich plasma products.

“We are pleased to welcome RegenLab to 95 Greene St. and are confident their talented team will thrive in their new state-of-the-art headquarters,” Thor Equities COO Melissa Gliatta commented. “Ideally located in one of the leading life science markets in the country, 95 Greene offers a range of amenities, unmatched access to talent, and central location just minutes from Manhattan.”

According to JLL, the firm has arranged approximately 75,000 square feet of new leases at the property. In addition to Jersey City Medical Center, that has included four relocations from New York City by life sciences companies: RegenLab; Fork & Good Inc., a cellular agriculture company; an unnamed tenant; and EpiBone.

That latter company, which grows bones and cartilage for skeletal reconstruction using stem cells, announced last spring it would relocate to the former Colgate Palmolive manufacturing plant after receiving $3.5 million over seven years in Emerge tax credits from the New Jersey Economic Development Authority.

Looking ahead, JLL anticipates that the Emerge program, along with the state’s skilled workforce, lab infrastructure and competitive pricing, will continue to attract life sciences companies in 2024.

If you build it …

Originally built as a manufacturing plant for Colgate Palmolive, 95 Greene St. is an eight-story, 350,000-square-foot property redeveloped by Thor Equities to meet demand from life science companies seeking custom space in well-located markets. - JLL
Originally built as a manufacturing plant for Colgate Palmolive, 95 Greene St. is an eight-story, 350,000-square-foot property redeveloped by Thor Equities to meet demand from life science companies seeking custom space in well-located markets. – JLL

Thor collaborated with SGA Architects on the adaptive reuse of 95 Greene St., which included extensive upgrades to mechanicals, HVAC, vertical conduits and a new rooftop generator, according to JLL.

The eight-story, 350,00-square-foot building is served by multiple utility grids and features 13-foot to 15-foot ceiling heights, secured interior loading docks, on-site life-safety generator, flexible floor plates and underground parking for 125 vehicles.

JLL Senior Managing Director Dan Spero, Managing Director Blake Goodman, Senior Vice Presidents John Cahill and Bob Ryan and Executive Vice President Craig Eisenhardt serve as exclusive agents for 95 Greene St. and represented and RegenLab in the lease negotiations.

“We are seeing significant activity from companies like RegenLab seeking to relocate from New York to best-in-class properties highly accessible to a skilled labor pool,” said Goodman. “95 Greene offers a powerful destination given its proximity to both NYC and NJ talent with great transit access from both sides.”